News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Deliver safe and stable products to your patients with the help of Catalent Biologics' Limoges, France site, a European Center of Excellence for early-phase clinical biologics formulation development and drug product fill/finish. It offers an integrated facility with a small-scale filling line, in-house analytical capabilities, quality control labs, cold storage, & regulatory support.
Process characterization and validation is an important step in the product development journey and late-phase development, and it is required before transferring an existing manufacturing process.
Process characterization is an important step in the product development journey. Download this Q&A article to learn the latest trends, status, and insights into process characterization and validation of monoclonal antibodies and recombinant proteins.
For more product information visit Catalent.